When STiR-communications began working with Cresilon in 2021, the company had breakthrough technology, a compelling founder story, and a rapidly expanding operation in Brooklyn. Despite its momentum, awareness remained limited.
As Cresilon continued to grow, the company needed greater visibility and third-party credibility to support fundraising, strategic partnerships, product adoption, and key business milestones. The challenge was not simply generating media coverage. It was helping put Cresilon on the radar of investors, industry leaders, and national media while positioning the company as a rising force in healthcare innovation.
Breakout Strategy / Programming
Cresilon is a Brooklyn-based biotechnology company developing and manufacturing proprietary plant-based gel technologies that rapidly stop severe bleeding in humans and animals.
Situation / Overview
Cresilon
Case Study
STiR developed and executed an ongoing public relations and media relations program designed to elevate both Cresilon and its founder, Joe Landolina, while creating awareness around the company's technology, growth, and key milestones.
Early efforts focused on building visibility through local, regional, and industry media while highlighting Cresilon's founder story, innovative technology, expanding biomanufacturing operation, and growing presence in New York City's biotech and life sciences sectors. As the company evolved, STiR continued identifying new stories and media opportunities tied to company growth, product innovation, industry recognition, and business milestones.
Outreach expanded to business, healthcare, and national media, securing coverage tied to fundraising activity, product innovation, industry recognition, and major company milestones. Over the course of the engagement, Cresilon earned coverage in outlets including FOX News, Forbes, CNN, Reuters, TIME, and Fast Company.
Media relations efforts continue to evolve alongside the company, supporting awareness around strategic partnerships, commercial growth initiatives, and other major milestones, including FDA clearance and the commercial launch of TRAUMAGEL.
Services Provided
PR Strategy
Earned Media
Award Nominations
Pitch Development
Key Message Development
Media Relations
Story Creation
Guest Speaking Engagements
Results
96
High-value editorial backlinks secured through earned media placements
1,100+
Media placements secured across national, industry, regional, broadcast, podcast, and online media
1.3 Billion+
Media impressions generated through earned media coverage since 2021
STiR secured coverage in outlets ranging from NY1 and Crain's New York Business to CNN, Reuters, FOX News, Forbes, TIME, and Fast Company, helping elevate Cresilon's profile from a growing Brooklyn biotech company to a nationally recognized healthcare innovator.
STiR secured recognition for Cresilon from leading media and industry organizations, including Fast Company's World's 50 Most Innovative Companies, TIME Best Inventions, the SXSW Innovation Awards, and Prix Galien USA.
STiR elevated CEO Joe Landolina's profile through media relations and award submissions, securing recognition including Forbes 30 Under 30 and honors from NYU, while landing a national television appearance on FOX Business' Mornings with Maria and a founder-focused feature story with Inc.
Sustained earned media visibility continues to support Cresilon's fundraising efforts, strategic partnerships, product adoption, commercialization goals, and long-term growth.
Sampling of Top Media Placements